Researcher
Anna Sablina
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
- See also: Anna Sablina (Flanders Institute for Biotechnology)
Affiliations
- Laboratory for Mechanisms of Cell Transformation (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - Laboratory for Mechanisms of Cell Transformation (VIB-KU Leuven) (Division)
Member
From1 Jan 2017 → Today - Sablina Lab (Research group)
Responsible
From1 Jan 2017 → Today - Department of Human Genetics (Department)
Member
From16 Apr 2009 → 31 Dec 2016
Projects
1 - 10 of 20
- Molecular structure and pharmacological activation of LZTR1 towards novel anticancer therapiesFrom20 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mapping the functional role of the low copy repeats in the phenotypic variability of the 22q11.2 Deletion SyndromeFrom27 Jan 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimize single -cell sequence approaches in PDACFrom14 Nov 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Micropeptides as novel biomarkers and precision medicine targets in cancerFrom26 Sep 2022 → 26 Jan 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Micropeptides in head and neck cancerFrom9 Nov 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting KRAS proteoastasis to develop personalized therapies for lung cancer patientsFrom1 Oct 2021 → TodayFunding: Foundations, funds and other with scientific goal
- Micropeptides as potential targets for cancer treatment in Lung AdenocarcinomaFrom18 Nov 2020 → 1 Jun 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- The role of LZTR1 in cancer development and progressionFrom10 Apr 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Alterations in RAS interactome triggered by ubiquitinationFrom1 Dec 2019 → 1 Dec 2023Funding: Own budget, for example: patrimony, inscription fees, gifts
- Nanobody-based approach to inhibit RAS activity by modultating its interactomeFrom1 Jan 2019 → 31 Dec 2022Funding: Foundations, funds and other with scientific goal
Publications
11 - 20 of 49
- Het ontrafelen van carboplatinum resistentie in tripel negatieve borstkanker(2021)
Authors: Stijn Moens, Frédéric Amant, Daniela Annibali, Anna Sablina
- Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13.(2021)
Authors: Maria Francesca Baietti, Raj Sewduth, Linde De Troyer, Maria Debiec-Rychter, Anna Sablina
Pages: 979 - 990 - The mitotic checkpoint is a targetable vulnerability of carboplatin-resistant triple negative breast cancers(2021)
Authors: Stijn Moens, Maria Francesca Baietti, Beppe Floris, Patrick Neven, Daniela Annibali, Anna Sablina, Frédéric Amant
- Targeting long non-coding RNAs in cancer therapies(2021)
Authors: Linde De Troyer, Anna Sablina, Sandra Nuyts
- Combining radiotherapy with DNA repair inhibitors as novel treatment strategy for head and neck cancers(2020)
Authors: Mary Glorieux, Sandra Nuyts, Anna Sablina, Rüveyda Dok
- Stress-induced lncRNA LASTR fosters cancer cell fitness by regulating the activity of the U4/U6 recycling factor SART3 (vol 48, pg 2502, 2020)(2020)
Authors: Linde De Troyer, Peihua Zhao, Tibor Pastor, Maria Francesca Baietti, Jasmine Barra, Roberto Vendramin, Rüveyda Dok, Benoit Lechat, Paul Najm, Delphi Van Haver, et al.
Pages: 5198 - 5199 - The Noonan Syndrome Gene Lztr1 Controls Cardiovascular Function by Regulating Vesicular Trafficking(2020)
Authors: Raj Sewduth, Aidana Sheryazdanova, Nathan Criem, Maria Francesca Baietti, Rozenn Quarck, Anna Sablina
Pages: 1379 - 1393 - Mutations in the ubiquitin ligase adaptor LZTR1 drive human disease by dysregulating RAS ubiquitination and signaling.(2020)
Authors: Mikhail Steklov, Silvia Pandolfi, Maria Francesca Baietti, Paolo Carai, Mingzhen Zhang, Hyunbum Jang, Yanyan Cai, Eric Legius, Jan Tavernier, Kris Gevaert, et al.
Pages: 39 - 39 - Cracking the Monoubiquitin Code of Genetic Diseases(2020)
Authors: Raj Sewduth, Maria Francesca Baietti, Anna Sablina
- The Mystery of Rap1 Suppression of Oncogenic Ras(2020)
Authors: Anna Sablina
Pages: 369 - 379